Patent · US Active

Peptides and methods for the detection of lyme disease antibodies

US8758772B2 · kind B2 · utility

10Cited by
32References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 2, 2012
Grant dateJun 24, 2014
Priority date
Expiry dateNov 2, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention provides compositions (e.g., peptide compositions) useful for the detection of antibodies that bind to Borrelia antigens. The peptide compositions comprise polypeptide sequences comprising variants in the IR6 domain of the Borrelia VlsE protein. The invention also provides devices, methods, and kits comprising such peptide compositions and useful for the detection of antibodies that bind to Borrelia antigens and the diagnosis of Lyme disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.